OPKO Health Q3 EPS $(0.11) Misses $(0.10) Estimate, Sales $178.60M Beat $174.78M Estimate
Portfolio Pulse from Benzinga Newsdesk
OPKO Health reported Q3 losses of $(0.11) per share, missing the analyst consensus estimate of $(0.10) by 10 percent. However, the company's quarterly sales of $178.60 million beat the analyst consensus estimate of $174.78 million by 2.19 percent.
November 06, 2023 | 9:55 pm
News sentiment analysis
Sort by:
Descending
NEUTRAL IMPACT
OPKO Health's Q3 earnings per share missed estimates, but sales exceeded expectations.
OPKO Health's earnings per share missed estimates, which could negatively impact the stock. However, the company's sales beat estimates, which could have a positive effect. The net impact is likely to be neutral.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100